Fairfield Financial Advisors’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-2,242
| Closed | -$147K | – | 81 |
|
|
2024
Q4 | $147K | Sell |
2,242
-590
| -21% | -$38.6K | 0.05% | 76 |
|
|
2024
Q3 | $221K | Sell |
2,832
-146
| -5% | -$11.4K | 0.08% | 67 |
|
|
2024
Q2 | $232K | Buy |
+2,978
| New | +$232K | 0.07% | 61 |
|
|
2023
Q4 | $168K | Buy |
2,490
+935
| +60% | +$63K | 0.06% | 81 |
|
|
2023
Q3 | $105K | Sell |
1,555
-289
| -16% | -$19.6K | 0.04% | 94 |
|
|
2023
Q2 | $132K | Hold |
1,844
| – | – | 0.05% | 81 |
|
|
2023
Q1 | $128K | Buy |
1,844
+26
| +1% | +$1.8K | 0.06% | 86 |
|
|
2022
Q4 | $123K | Hold |
1,818
| – | – | 0.06% | 87 |
|
|
2022
Q3 | $99.7K | Sell |
1,818
-136
| -7% | -$7.46K | 0.05% | 88 |
|
|
2022
Q2 | $129K | Hold |
1,954
| – | – | 0.06% | 77 |
|
|
2022
Q1 | $130K | Buy |
+1,954
| New | +$130K | 0.05% | 76 |
|